Dhamanti Inge, Suwantika Auliya A, Adlia Amirah, Yamani Laura Navika, Yakub Fitri
Department of Health Policy and Administration, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia.
Center for Patient Safety Research, Universitas Airlangga, Surabaya, Indonesia.
Int J Gen Med. 2023 Feb 20;16:609-618. doi: 10.2147/IJGM.S400458. eCollection 2023.
The COVID-19 pandemic had a severe global impact. A range of campaigns and activities, including vaccines, are being implemented to counteract this pandemic. Using observational data, the goal of this scoping review is to identify adverse events connected with COVID-19 vaccinations. We conduct a scoping study and searched three databases from the start of the COVID-19 pandemic in 2020 through June 2022. Based on our criteria and searched keywords, the review included eleven papers in total, with the majority of the studies being conducted in developed countries. The study populations varied and included general community populations, healthcare professionals, military forces, and patients with systemic lupus and cancer. This study includes vaccines from Pfizer-BioNTech, Oxford-AstraZeneca, Sinopharm, and Moderna. The COVID-19 vaccine-related adverse events were classified into three types: local side effects, systemic side effects, and other side effects such as allergies. The adverse reactions to COVID-19 vaccines are mild to moderate in severity, with no significant influence or interference in individual daily activities and no unique patterns in cause of death among vaccine-related deaths. According to the findings of these investigations, the COVID-19 vaccine is safe to administer and induces protection. It is vital to convey accurate information to the public about vaccination side effects, potential adverse responses, and the safety level of the vaccines supplied. Multiple strategies must be implemented at the individual, organizational, and population levels to eliminate vaccine hesitance. Future studies could investigate the vaccine's effect on people of various ages and medical conditions.
新冠疫情对全球产生了严重影响。包括疫苗在内的一系列活动正在开展,以对抗这一疫情。本综述性研究旨在利用观察性数据,识别与新冠疫苗接种相关的不良事件。我们进行了一项综述性研究,检索了三个数据库,检索时间从2020年新冠疫情开始至2022年6月。根据我们的标准和检索关键词,该综述共纳入11篇论文,大多数研究在发达国家开展。研究人群各不相同,包括普通社区人群、医护人员、军队以及系统性红斑狼疮和癌症患者。本研究涵盖了辉瑞-生物科技、牛津-阿斯利康、国药集团和莫德纳的疫苗。与新冠疫苗相关的不良事件分为三种类型:局部副作用、全身副作用以及过敏等其他副作用。新冠疫苗的不良反应严重程度为轻至中度,对个人日常活动无重大影响或干扰,在与疫苗相关的死亡病例中,死因无独特模式。根据这些调查结果,新冠疫苗接种安全且能产生保护作用。向公众传达有关疫苗接种副作用、潜在不良反应以及所供应疫苗安全水平的准确信息至关重要。必须在个人、组织和人群层面实施多种策略,以消除疫苗犹豫情绪。未来的研究可以调查疫苗对不同年龄和健康状况人群的影响。